- EMA OKs First Therapy for Non-Cystic Fibrosis Bronchiectasis Medscape
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 October 2025 European Medicines Agency
- Press Release: Sanofi’s Wayrilz recommended for…
Category: 6. Business
-
EMA OKs First Therapy for Non-Cystic Fibrosis Bronchiectasis – Medscape
-
Accounting Firms Say Foreign Issuers Face Major Obstacles if SEC Mandates US GAAP
In comment letters, prominent accounting firms highlighted the costs and practical challenges for foreign private issuers (FPIs) if the Securities and Exchange Commission (SEC) required them to file their financial statements that…
Continue Reading
-
The long bond yield is heading below 4% and gold to $6,000 by next spring, predicts Bank of America
By Jules Rimmer
Investors face limited options when it comes to allocating capital
Bank of America’s strategist Michael Hartnett makes a couple of eye-catching calls on bonds and gold.
Buy longer-dated Treasury bonds and…
Continue Reading
-
Using captives to unlock value in affinity insurance programs
In today’s competitive business landscape, affinity insurance programs that overlook captive solutions risk falling behind.
Our new report, Using captives to unlock value in affinity insurance programs, in partnership with the Open &…
Continue Reading
-
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin
- Acquisition expands AbbVie’s psychiatry pipeline with the addition of a next-generation psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD).
NORTH CHICAGO, Ill., Oct. 17, 2025 /PRNewswire/…
Continue Reading
-
A genome-wide analysis of ascorbate oxidase gene family and hormonal activity in mango exposed to enhanced UV-B radiation | BMC Plant Biology
Pérez V, Herrero M, Hormaza J. Self-fertility and preferential cross-fertilization in mango (Mangifera indica). Sci Hortic. 2016;213:373–8.
Google Scholar
Jaglan P, Buttar HS, Al-bawareed O,…
Continue Reading
-
Novartis Kisqali® 5-year NATALEE data demonstrate 28% reduction in risk of recurrence in the broadest early breast cancer patient population – Novartis
- Novartis Kisqali® 5-year NATALEE data demonstrate 28% reduction in risk of recurrence in the broadest early breast cancer patient population Novartis
- Timothée Olivier: Revisiting NATALEE Results Through Sensitivity Analyses Oncodaily
- Novartis…
Continue Reading
-
Lawrence Hill rail station to become step free with new lift
Avalon/Getty ImagesThe stairs seen on the left are currently the only way of accessing platform two An inner-city rail station is to become entirely step free for the first time in 162 years after plans for a lift were approved.
Bristol City…
Continue Reading
-
CYBER TYRE AWARDED AS THE MOST INNOVATIVE TYRE TECHNOLOGY AT THE AUTOTECH BREAKTHROUGH AWARDS 2025
Awarded as “V2X Innovation of the Year”, Pirelli Cyber Tyre is the world’s first system that collects data from tyres and processes them to optimise the vehicle’s control electronics.
Pirelli’s technology has been…
Continue Reading
-
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
Acquisition to expand the neuromodulation offerings for people living with chronic pain
MARLBOROUGH, Mass., Oct. 17, 2025 /PRNewswire/ — Boston Scientific Corporation (NYSE:…
Continue Reading
